Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABS) Debt Ratio (2020 - 2022)

Historic Debt Ratio for SAB Biotherapeutics (SABS) over the last 2 years, with Q4 2022 value amounting to 0.01.

  • SAB Biotherapeutics' Debt Ratio changed N/A to 0.01 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.01, marking a year-over-year change of. This contributed to the annual value of 0.01 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, SAB Biotherapeutics' Debt Ratio is 0.01.
  • SAB Biotherapeutics' Debt Ratio's 5-year high stood at 0.01 during Q4 2022, with a 5-year trough of 0.0 in Q4 2020.